SEC Form 4 · accession 0001104659-19-010799
SUPERNUS PHARMACEUTICALS, INC. · SUPN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory S Patrick
Officer — Sr.VP,Chief Financial Officer
Period of report
Feb 22, 2019
Accepted (ET)
Feb 26, 2019 · 7:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001356576
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 47,896 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $36.75 | Feb 22, 2019 | A | 40,000 | A | — | Feb 22, 2029 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1The option vests in four equal annual installments beginning on February 22, 2020.